Delivery Order SPE2DB20D1100-SPE2DB25FD7C1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,413.11 to AmerisourceBergen Drug Corp for the supply of Doxycycline Mono 100 mg tablets (250-count unit) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Doxycycline 50 mg tablets in quantities of 60 units, with a ceiling value of $47,967.46. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,736.07 to AmerisourceBergen Drug Corp for the procurement of Doxycycline Hyclate 100 mg tablets (1,000 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order was issued under a firm fixed price structure with no set-aside designation, awarded through open competition. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. As...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,099.86 to AmerisourceBergen Drug Corp for the supply of Doxycycline 50 mg tablets (60-count packages) with an ultimate completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,094.92 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with completion required by December 23, 2025. This contract was awarded on a non-competitive, firm fixed-price basis and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader contract...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,248,437 doxycycline 50 mg tablets. The contract, valued at $16,543.56, has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania. This delivery order is placed under an...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.85 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 20 mg tablets (90-count packaging) on January 28, 2026, with completion scheduled for January 29, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,199.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Doxycycline Monohydrate 100 mg capsules (250-count units) valued at $1,571.53 with a firm fixed price structure. The order, issued on September 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by September 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery, which supports...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7C1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,456.56 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg tablets (250 count) with a completion date of July 30, 2025. This competitive award utilizes firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen Drug Corp's location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order represents a task under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Through this prime contract vehicle, AmerisourceBergen supplies a vast range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs and other government healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/29/25 |